THANK YOU ECOR
electroCore Inc
0.32
0.01 (3.23%)
Volume: 150,236
Day Range: 0.30 - 0.33974
Bid: 0.32
Ask: 0.338
Last Trade Time: 6:44:54 PM EST
Total Trades: 294
electroCore Inc
0.32
0.01 (3.23%)
Volume: 150,236
Day Range: 0.30 - 0.33974
Bid: 0.32
Ask: 0.338
Last Trade Time: 6:44:54 PM EST
Total Trades: 294
Recent ECOR News
- electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:01:05 PM
- electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD • GlobeNewswire Inc. • 04/01/2026 12:00:00 PM
- electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/31/2026 12:00:00 PM
- electroCore Expands Intellectual Property Portfolio • GlobeNewswire Inc. • 03/30/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 10:01:50 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/19/2026 09:22:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:35:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:10:30 PM
- electroCore Announces Full Year 2025 Financial Results and Organizational Changes • GlobeNewswire Inc. • 03/19/2026 08:05:00 PM
- electroCore to Participate at the 38th Annual Roth Conference • GlobeNewswire Inc. • 03/10/2026 12:00:00 PM
- electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 • GlobeNewswire Inc. • 03/09/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 09:30:06 PM
- Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”) • GlobeNewswire Inc. • 01/21/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 09:05:52 PM
- electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million • GlobeNewswire Inc. • 01/20/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:15:45 PM
- TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen • GlobeNewswire Inc. • 12/02/2025 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/13/2025 07:27:02 PM
- electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum • GlobeNewswire Inc. • 11/10/2025 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 09:16:00 PM
- electroCore Announces Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/05/2025 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/24/2025 09:15:42 PM
- electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025 • GlobeNewswire Inc. • 10/23/2025 12:11:51 PM
